|
- 积分
- 279
- 威望
- 279
- 包包
- 128
|
Title: CD133: molecule of the moment.% C2 ~' u! k' ~+ X. ~0 I
Author: Mizrak, D.; Brittan, M.; Alison, M. R.1 O3 ~3 R9 g: W* q7 b0 p" V
Source: J Pathol, 2008, 214(1): 3-9: [1 A2 i$ `1 q( j: _1 M7 a
' _ k" ~6 U5 V1 T* G* Z
Title: Focus on molecules: prominin-1 (CD133).
5 [. a, z) W/ c9 _3 gAuthor: Jaszai, J.; Fargeas, C. A.; Florek, M. (...)6 P# d% o. s1 Q( ]( H" e7 T* a1 V
Source: Exp Eye Res, 2007, 85(5): 585-586
( L; V7 K1 i3 J6 Y% T4 \% ]5 `2 u2 {
Title: CD133.' N& v: C& Y7 Z" Y+ |. V
Author: Piechaczek, C.
( W9 F6 `# {6 g" N8 F& i& VSource: J Biol Regul Homeost Agents, 2001, 15(1): 101-1028 N H6 `; c/ k c7 j7 B+ j; N
0 n" I W" s5 l3 HTitle: CD133 as a marker for cancer stem cells: progresses and concerns.
" r2 {, b# _, @- J2 D0 {( E0 BAuthor: Wu, Y.; Wu, P. Y.5 [9 Z& ]4 n* Q1 r2 Q* k- w7 c
Source: Stem Cells Dev, 2009, 18(8): 1127-1134
) d. h, ]2 v) e5 P3 n0 Q7 u
, X* H; h# W+ m! h& \$ J% HTitle: Risk and benefit of CD133+ progenitors.
2 n5 c2 z( ~+ c) b: J) w/ t( [Author: Ascione, R.; Madeddu, P.
* P; @! C3 g+ S, n% o9 TSource: Circ Res, 2009, 105(2): e2; d B) `1 @" P/ M* ]9 Q
8 b' [$ }0 _2 n0 X1 I g
Title: Targeting CD133 antigen in cancer.
( F0 f0 g; _1 V1 A6 \* Y, S: @Author: Ferrandina, G.; Petrillo, M.; Bonanno, G. (...)
x, Q; \2 h) ?Source: Expert Opin Ther Targets, 2009, 13(7): 823-837
- f) s6 H4 ?- K$ \) j* v' ~" H0 p1 Y% ?, e$ E' i" T9 j
Title: Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
, E; r4 q; {* _% p5 s/ WAuthor: Ogden, A. T.; Waziri, A. E.; Lochhead, R. A. (...)9 F* C9 w% ^$ a* r. v4 ]
Source: Neurosurgery, 2008, 62(2): 505-514, 514-515 |
|
发表于 2010-7-9 14:12
发表于 2010-7-9 22:47
rogresses and Concerns不好意思，没看到楼上的已经发了这一篇